CONDENSED RING COMPOUND AND ITS MEDICINAL USE

Japanese Patent JP2001247550

A

To obtain a therapeutic agent and a prophylactic showing an anti-HCV action by a HCV polymerase inhibitory action, effective against hepatitis C.

This condensed ring compound is represented by general formula [I] (each sign is as shown in the specification) or the like or its pharmaceutically acceptable salt. This therapeutic agent against hepatitis C comprises the compound. The compound shows an anti-HCV action by a hepatitis C virus(HCV) polymerase inhibitory action and is useful as a therapeutic agent or an prophylactic for hepatitis C.

JP5805209	Benzimidazole derivatives for use in light emitting devices
JP2015532650	Use of substituted 2-amide benzimidazoles, 2-amide benzoxazoles and 2-amide benzothiazoles or salts thereof as active substances against abiotic plant stress
JP2024056694	2-Arylbenzimidazoles as Ppargc1a activators to treat neurodegenerative diseases

HASHIMOTO HIROMASA
MIZUTANI KENJI
YOSHIDA ATSUHITO

JP2000391904A

September 11, 2001

December 25, 2000

Click for automatic bibliography generation  

JAPAN TOBACCO INC

C07D235/18; A61K31/4184; A61K31/422; A61K31/426; A61K31/4427; A61K31/443; A61K31/4433; A61K31/4439; A61K31/454; A61K31/496; A61P1/16; A61P31/12; C07D235/30; C07D401/04; C07D401/12; C07D401/14; C07D403/04; C07D403/12; C07D405/04; C07D405/12; C07D409/04; C07D409/12; C07D413/04; C07D413/12; (IPC1-7): C07D235/18; A61K31/4184; A61K31/422; A61K31/426; A61K31/4439; A61K31/454; A61K31/496; A61P1/16; A61P31/12; C07D235/30; C07D401/04; C07D401/12; C07D401/14; C07D403/04; C07D403/12; C07D405/04; C07D405/12; C07D409/04; C07D409/12; C07D413/04; C07D413/12

Teruo Daito

Previous Patent: METHOD OF PRODUCING 1-POSITION SUBSTITUTED HYDANTOINS

Next Patent: METHOD OF PRODUCING 5-PERFLUOROALKTLURACIL DERIVATIVE